Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal

Mar 30, 2026 05:55 am UTC| Business Health

Eli Lilly has entered a landmark drug discovery partnership with Insilico Medicine, a Hong Kong-listed biotechnology company, in an agreement that could be worth up to $2.75 billion. The deal signals a major step forward...

The four types of dementia most people don’t know exist

Mar 27, 2026 05:18 am UTC| Insights & Views Health

What most people think of when they hear the word dementia is memory problems and forgetfulness. But what people often dont know is that dementia can cause many different symptoms affecting speech, behaviour, sleep, motor...

Is dark chocolate healthier than milk chocolate? 2 dietitians explain

Mar 27, 2026 04:29 am UTC| Insights & Views Health

Easter chocolate is all over supermarket shelves. Some people reach straight for milk chocolate eggs while others pause at the darker varieties, assuming theyre healthier. Dark chocolate has gained a reputation as the...

U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil

Mar 20, 2026 02:46 am UTC| Governance Politics Health

The United States is moving closer to naming a permanent leader for the Centers for Disease Control and Prevention, according to a top health official. Chris Klomp, chief counselor at the Department of Health and Human...

FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes

Mar 07, 2026 05:05 am UTC| Health Governance Business

Dr. Vinay Prasad, the controversial director of the U.S. Food and Drug Administrations Center for Biologics Evaluation and Research (CBER), will step down from his role at the end of April, according to FDA Commissioner...

FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims

Mar 04, 2026 01:16 am UTC| Business Health Governance

The U.S. Food and Drug Administration (FDA) has issued a warning to Danish pharmaceutical giant Novo Nordisk regarding a consumer advertisement for its widely used diabetes drug, Ozempic. According to the regulator, the ad...

Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology

Mar 04, 2026 01:01 am UTC| Business Health Law

Moderna has reached a major legal settlement worth up to $2.25 billion with Genevant Sciences and Arbutus Biopharma, ending a long-running patent dispute over the lipid nanoparticle (LNP) technology used in its COVID-19...